Many Bright Ideas Technologies Inc.

TSXV:MBI.H Stock Report

Market Cap: CA$345.2k

Many Bright Ideas Technologies Past Earnings Performance

Past criteria checks 0/6

Many Bright Ideas Technologies has been growing earnings at an average annual rate of 1.5%, while the Biotechs industry saw earnings growing at 22.1% annually.

Key information

1.5%

Earnings growth rate

11.8%

EPS growth rate

Biotechs Industry Growth51.1%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update30 Sep 2024

Recent past performance updates

No updates

Recent updates

Estimating The Fair Value Of Many Bright Ideas Technologies Inc. (CVE:MBI.H)

Apr 26
Estimating The Fair Value Of Many Bright Ideas Technologies Inc. (CVE:MBI.H)

Have Med BioGene Inc. (CVE:MBI.H) Insiders Been Selling Their Stock?

Feb 21
Have Med BioGene Inc. (CVE:MBI.H) Insiders Been Selling Their Stock?

Revenue & Expenses Breakdown

How Many Bright Ideas Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSXV:MBI.H Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 240000
30 Jun 240000
31 Mar 240000
31 Dec 230000
30 Sep 230000
30 Jun 230000
31 Mar 230000
31 Dec 220000
30 Sep 220000
30 Jun 220000
31 Mar 220000
31 Dec 210000
30 Sep 210000
30 Jun 210000
31 Mar 210000
31 Dec 200000
30 Sep 200000
30 Jun 200000
31 Mar 200000
31 Dec 190000
30 Sep 190000
30 Jun 190000
31 Mar 190000
31 Dec 180000
30 Sep 180000
30 Jun 180000
31 Mar 180000
31 Dec 170000
30 Sep 170000
30 Jun 170000
31 Mar 170000
31 Dec 160000
30 Sep 160000
30 Jun 160000
31 Mar 160000
31 Dec 150000
30 Sep 150000
30 Jun 150000
31 Mar 150000
31 Dec 140000
30 Sep 140000
30 Jun 140-110
31 Mar 140-110

Quality Earnings: MBI.H is currently unprofitable.

Growing Profit Margin: MBI.H is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MBI.H is unprofitable, but has reduced losses over the past 5 years at a rate of 1.5% per year.

Accelerating Growth: Unable to compare MBI.H's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MBI.H is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (16.6%).


Return on Equity

High ROE: MBI.H's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies